The toxicity redox mechanisms of cadmium alone or together with copper and zinc homeostasis alteration: Its redox biomarkers

Journal of Trace Elements in Medicine and Biology

Volumn 25, Issue 3, 2011, Pages 171-180

  Nzengue, Yves ^a,b   Candéias, Serge M ^a   Sauvaigo, Sylvie ^a   Douki, Thierry ^a   Favier, Alain ^a   Rachidi, Walid ^a   Guiraud, Pascale ^c  

^a CEA GRENOBLE   (France)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITÉ DE LA RÉUNION   (France)

Author keywords

Biomarkers; Cadmium; Copper; GSH; MT; MTF 1; P53; Zinc

Indexed keywords

ANTIOXIDANT; CADMIUM; CADMIUM CHLORIDE; COPPER; COPPER CHLORIDE; DNA; GLUTATHIONE; METAL RESPONSIVE TRANSCRIPTION FACTOR 1; METALLOTHIONEIN; PROTEIN P53; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ZINC; ZINC CHLORIDE;

ARTICLE; CELL DAMAGE; CELL LEVEL; CELL SPECIFICITY; CELL TRANSPORT; COPPER HOMEOSTASIS; COPPER METABOLISM; DETOXIFICATION; DNA DAMAGE; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION; GLUTATHIONE METABOLISM; HOMEOSTASIS; HUMAN; LIPID PEROXIDATION; METAL BINDING; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; TOXICOKINETICS; ZINC HOMEOSTASIS; ZINC METABOLISM;

ANIMALS; BIOLOGICAL MARKERS; CADMIUM; COPPER; HOMEOSTASIS; HUMANS; OXIDATION-REDUCTION; ZINC;

EID: 80052768714     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2011.06.002     Document Type: Article

References (249)

1. Benavides M.P., Gallego S.M., Tomaro M.L. Cadmium toxicity in plants. Braz J Plant Physiol 2005, 17:21-34.
2. Barazani O., Dudai N., Khadka U.R., Golan-Goldhirsh A. Cadmium accumulation in Allium schoenoprasum L. grown in an aqueous medium. Chemosphere 2004, 57:1213-1218.
3. Irwin RVM, Stevend M, Seese L, MD. Basham, W. Environmental contaminants encyclopedia. National Park Service, Water Resources Division, Fort Collins, Colorado. Distributed within the federal government as electronic document 2003.
4. Valko M., Morris H., Cronin M.T. Metals, toxicity and oxidative stress. Curr Med Chem 2005, 12:1161-1208.
5. Valko M., Izakovic M., Mazur M., Rhodes C.J., Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 2004, 266:37-56.
6. Nordberg G.F. Historical perspectives on cadmium toxicology. Toxicol Appl Pharmacol 2009, 238:192-200.
7. Jarup L. Cadmium overload and toxicity. Nephrol Dial Transplant 2002, 17(Suppl. 2):35-39.
8. Waisberg M., Joseph P., Hale B., Beyersmann D. Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology 2003, 192:95-117.
9. Fassett D.W. Cadmium: biological effects and occurrence in the enviroment. Annu Rev Pharmacol 1975, 15:425-435.
10. He Z.L., Yang X.E., Stoffella P.J. Trace elements in agroecosystems and impacts on the environment. J Trace Elem Med Biol 2005, 19:125-140.
11. Jarup L. Hazards of heavy metal contamination. Br Med Bull 2003, 68:167-182.
12. Trinchella F., Riggio M., Filosa S., Volpe M.G., Parisi E., Scudiero R. Cadmium distribution and metallothionein expression in lizard tissues following acute and chronic cadmium intoxication. Comp Biochem Physiol C Toxicol Pharmacol 2006, 144:272-278.
13. (IARC) IAFROC Beryllium, cadmium, mercury, and exposures in the glass manufacturing industry. International agency for research on cancer monographs on the evaluation of carcinogenic risks to humans 1993, vol. 58:119-1237. IARC Scientific Publications, Lyon.
14. Oh S.H., Choi J.E., Lim S.C. Protection of betulin against cadmium-induced apoptosis in hepatoma cells. Toxicology 2006, 220:1-12.
15. Program NT. Ninth report on carcinogens. National Toxicology Program, Research Triangle Park, NC, USA; 2000.
16. WHO Cadmium. Environmental health criteria 1992, World Health Organization, Geneva.
17. Schwartz G.G., Reis I.M. Is cadmium a cause of human pancreatic cancer?. Cancer Epidemiol Biomarkers Prev 2000, 9:139-145.
18. Joseph P. Mechanisms of cadmium carcinogenesis. Toxicol Appl Pharmacol 2009, 238:272-279.
19. Sahmoun A.E., Case L.D., Jackson S.A., Schwartz G.G. Cadmium and prostate cancer: a critical epidemiologic analysis. Cancer Invest 2005, 23:256-263.
20. Goon D., Klaassen C.D. Dosage-dependent absorption of cadmium in the rat intestine measured in situ. Toxicol Appl Pharmacol 1989, 100:41-50.
21. Klaassen C.D., Liu J., Diwan B.A. Metallothionein protection of cadmium toxicity. Toxicol Appl Pharmacol 2009, 238:215-220.
22. Jarup L., Akesson A. Current status of cadmium as an environmental health problem. Toxicol Appl Pharmacol 2009, 238:201-208.
23. Jin T., Lu J., Nordberg M. Toxicokinetics and biochemistry of cadmium with special emphasis on the role of metallothionein. Neurotoxicology 1998, 19:529-535.
24. Bhattacharyya M.H. Cadmium osteotoxicity in experimental animals: mechanisms and relationship to human exposures. Toxicol Appl Pharmacol 2009, 238:258-265.
25. Ezaki T., Tsukahara T., Moriguchi J., Furuki K., Fukui Y., Ukai H., et al. No clear-cut evidence for cadmium-induced renal tubular dysfunction among over 10,000 women in the Japanese general population: a nationwide large-scale survey. Int Arch Occup Environ Health 2003, 76:186-196.
26. Kjellstrom T. Renal effects. In: Fribeberg L, Elinder CG, Kjellstrom T, Nordberg G, editors. Cadmium and health. A toxicological and epidemiological appraisal. General Aspects. Effects and response. Boca Raton, Florida; 1986. p. 21-109.
27. Horiguchi H., Teranishi H., Niiya K., Aoshima K., Katoh T., Sakuragawa N., et al. Hypoproduction of erythropoietin contributes to anemia in chronic cadmium intoxication: clinical study on Itai-itai disease in Japan. Arch Toxicol 1994, 68:632-636.
28. Hiratsuka H., Katsuta O., Toyota N., Tsuchitani M., Umemura T., Marumo F. Chronic cadmium exposure-induced renal anemia in ovariectomized rats. Toxicol Appl Pharmacol 1996, 137:228-236.
29. Sakata S., Iwami K., Enoki Y., Kohzuki H., Shimizu S., Matsuda M., et al. Effects of cadmium on in vitro and in vivo erythropoiesis: erythroid progenitor cells (CFU-E), iron, and erythropoietin in cadmium-induced iron deficiency anemia. Exp Hematol 1988, 16:581-587.
30. Tellez-Plaza M., Navas-Acien A., Crainiceanu C.M., Guallar E. Cadmium exposure and hypertension in the 1999-2004 National Health and Nutrition Examination Survey (NHANES). Environ Health Perspect 2008, 116:51-56.
31. Edwards J.R., Prozialeck W.C. Cadmium, diabetes and chronic kidney disease. Toxicol Appl Pharmacol 2009, 238:289-293.
32. Messner B., Knoflach M., Seubert A., Ritsch A., Pfaller K., Henderson B., et al. Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance. Arterioscler Thromb Vasc Biol 2009, 29:1392-1398.
33. Hubert N., Hentze M.W. Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function. Proc Natl Acad Sci USA 2002, 99:12345-12350.
34. Barbier O., Jacquillet G., Tauc M., Cougnon M., Poujeol P. Effect of heavy metals on, and handling by, the kidney. Nephron Physiol 2005, 99:105-110.
35. Olivi L., Sisk J., Bressler J. Involvement of DMT1 in uptake of Cd in MDCK cells: role of protein kinase C. Am J Physiol Cell Physiol 2001, 281:C793-C800.
36. Tallkvist J., Bowlus C.L., Lonnerdal B. DMT1 gene expression and cadmium absorption in human absorptive enterocytes. Toxicol Lett 2001, 122:171-177.
37. He L., Wang B., Hay E.B., Nebert D.W. Discovery of ZIP transporters that participate in cadmium damage to testis and kidney. Toxicol Appl Pharmacol 2009, 238:250-257.
38. Dalton T.P., He L., Wang B., Miller M.L., Jin L., Stringer K.F., et al. Identification of mouse SLC39A8 as the transporter responsible for cadmium-induced toxicity in the testis. Proc Natl Acad Sci USA 2005, 102:3401-3406.
39. He L., Girijashanker K., Dalton T.P., Reed J., Li H., Soleimani M., et al. ZIP8, member of the solute-carrier-39 (SLC39) metal-transporter family: characterization of transporter properties. Mol Pharmacol 2006, 70:171-180.
40. Leslie E.M., Deeley R.G., Cole S.P. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol 2005, 204:216-237.
41. Paulusma C.C., Kool M., Bosma P.J., Scheffer G.L., ter Borg F., Scheper R.J., et al. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology 1997, 25:1539-1542.
42. Dijkstra M., Havinga R., Vonk R.J., Kuipers F. Bile secretion of cadmium, silver, zinc and copper in the rat. Involvement of various transport systems. Life Sci 1996, 59:1237-1246.
43. Ballatori N., Hammond C.L., Cunningham J.B., Krance S.M., Marchan R. Molecular mechanisms of reduced glutathione transport: role of the MRP/CFTR/ABCC and OATP/SLC21A families of membrane proteins. Toxicol Appl Pharmacol 2005, 204:238-255.
44. Pillai A., Gupta S. Antioxidant enzyme activity and lipid peroxidation in liver of female rats co-exposed to lead and cadmium: effects of vitamin E and Mn2+. Free Radic Res 2005, 39:707-712.
45. Fotakis G., Timbrell J.A. Modulation of cadmium chloride toxicity by sulphur amino acids in hepatoma cells. Toxicol In Vitro 2006, 20:641-648.
46. Yang M.S., Lai K.P., Cheng K.Y., Wong C.K. Changes in endogenous Zn and Cu distribution in different cytosolic protein fractions in mouse liver after administration of a single sublethal dose of CdCl(2). Toxicology 2000, 154:103-111.
47. Martelli A., Rousselet E., Dycke C., Bouron A., Moulis J.M. Cadmium toxicity in animal cells by interference with essential metals. Biochimie 2006, 88:1807-1814.
48. Liu J., Qu W., Kadiiska M.B. Role of oxidative stress in cadmium toxicity and carcinogenesis. Toxicol Appl Pharmacol 2009, 238:209-214.
49. Jacob C., Maret W., Vallee B.L. Control of zinc transfer between thionein, metallothionein, and zinc proteins. Proc Natl Acad Sci USA 1998, 95:3489-3494.
50. Maret W. Oxidative metal release from metallothionein via zinc-thiol/disulfide interchange. Proc Natl Acad Sci USA 1994, 91:237-241.
51. Miles A.T., Hawksworth G.M., Beattie J.H., Rodilla V. Induction, regulation, degradation, and biological significance of mammalian metallothioneins. Crit Rev Biochem Mol Biol 2000, 35:35-70.
52. Parks D., Bolinger R., Mann K. Redox state regulates binding of p53 to sequence-specific DNA, but not to non-specific or mismatched DNA. Nucleic Acids Res 1997, 25:1289-1295.
53. Bielski BHJ, Cabelli DE. Superoxide and hydroxyl radical chemistry in aqueous solution. In: Foote CS, Valentine JS, Greenberg A, Liebman, JF, editors. Active oxygen in chemistry; 1995. p. 66-104.
54. Halliwell B., Gutteridge J.M. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 1984, 219:1-14.
55. Linder M.C., Lomeli N.A., Donley S., Mehrbod F., Cerveza P., Cotton S., et al. Copper transport in mammals. Adv Exp Med Biol 1999, 448:1-16.
56. Zhou B., Gitschier J. hCTR1: a human gene for copper uptake identified by complementation in yeast. Proc Natl Acad Sci USA 1997, 94:7481-7486.
57. Harrison M.D., Jones C.E., Solioz M., Dameron C.T. Intracellular copper routing: the role of copper chaperones. Trends Biochem Sci 2000, 25:29-32.
58. Frelon S., Douki T., Favier A., Cadet J. Hydroxyl radical is not the main reactive species involved in the degradation of DNA bases by copper in the presence of hydrogen peroxide. Chem Res Toxicol 2003, 16:191-197.
59. Ravanat J.L., Di Mascio P., Martinez G.R., Medeiros M.H., Cadet J. Singlet oxygen induces oxidation of cellular DNA. J Biol Chem 2000, 275:40601-40604.
60. Hultberg M., Isaksson A., Andersson A., Hultberg B. Traces of copper ions deplete glutathione in human hepatoma cell cultures with low cysteine content. Chem Biol Interact 2007, 167:56-62.
61. Guiraud P., Horn A.F.N. Metabolism of copper. Encycl Méd Chir 2003, 10-359.
62. Pena M.M., Lee J., Thiele D.J. A delicate balance: homeostatic control of copper uptake and distribution. J Nutr 1999, 129:1251-1260.
63. Multhaup G., Ruppert T., Schlicksupp A., Hesse L., Bill E., Pipkorn R., et al. Copper-binding amyloid precursor protein undergoes a site-specific fragmentation in the reduction of hydrogen peroxide. Biochemistry 1998, 37:7224-7230.
64. Rotilio G., Carri M.T., Rossi L., Ciriolo M.R. Copper-dependent oxidative stress and neurodegeneration. IUBMB Life 2000, 50:309-314.
65. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59-62.
66. Vallee B.L., Auld D.S. Zinc coordination, function, and structure of zinc enzymes and other proteins. Biochemistry 1990, 29:5647-5659.
67. Kindermann B., Doring F., Budczies J., Daniel H. Zinc-sensitive genes as potential new target genes of the metal transcription factor-1 (MTF-1). Biochem Cell Biol 2005, 83:221-229.
68. Chesters J.K., Petrie L., Vint H. Specificity and timing of the Zn2+ requirement for DNA synthesis by 3T3 cells. Exp Cell Res 1989, 184:499-508.
69. Prasad A.S., Beck F.W., Endre L., Handschu W., Kukuruga M., Kamar G. Zinc deficiency affects cell cycle and deoxythymidine kinase gene expression in HUT-78 cells. J Clin Med 1996, 128:51-60.
70. Schroeder J.J., Cousins R.J. Interleukin 6 regulates metallothionein gene expression and zinc metabolism in hepatocyte monolayer cultures. Proc Natl Acad Sci USA 1990, 87:3137-3141.
71. Chia S.E., Ong C.N., Chua L.H., Ho L.M., Tay S.K. Comparison of zinc concentration in blood and seminal plasma and the various sperm parameters between fertile and infertile men. J Androl 2000, 21:53-57.
72. Henkel R., Bittner J., Weber R., Huther F., Miska W. Relevance of zinc in human sperm flagella and its relation to mobility. Fertil Steril 1999, 71:1138-1143.
73. Netter A., Hartoma R., Nahoul K. Effect of zinc administration on plasma testosterone, dihydrotestosterone, and sperm count. Arch Androl 1981, 7:69-73.
74. Favier A. Hormonal effects of zinc on growth in chilgren. Biol Trace Elem Res 1992, 32:383-398.
75. Chimienti F., Seve M., Richard S., Mathieu J., Favier A. Role of cellular zinc in programmed cell death: temporal relation-ship between zinc depletion, activation of caspases and cleavage of Sp family transcription factors. Biochem Pharmacol 2001, 62:51-62.
76. Chvapil M., Stankova L., Zukoski C. Inhibition of some functions of polymorphonuclear leukocytes by in vitro zinc. J Lab Clin Med 1977, 89:135-146.
77. Favier A. Zinc-ligand interactions and oxygen free radicals formation in Handbook on metal-ligand interactions in biological fluids. Bioinorganic chemistry 1995, 876-887. Marcel Dekker, New York. G. Berthon (Ed.).
78. Koukay N, Favier A. Zinc et radicaux libres (étude in vitro). In: Le zinc en médecine et biologie. Paris, Techniques et Documentation; 1987. p. 64-8.
79. Wilson R. Zinc and iron in free radical pathology and cellular control. Zinc in human biology 1988, 147-172. Springer-Verlag, Berlin.
80. Chimienti F., Seve M., Richard S., Mathieu J., Favier A. Role of cellular zinc in programmed cell death: temporal relationship between zinc depletion, activation of caspases, and cleavage of Sp family transcription factors. Biochem Pharmacol 2001, 62:51-62.
81. Cousins R.J., Liuzzi J.P., Lichten L.A. Mammalian zinc transport, trafficking, and signals. J Biol Chem 2006, 281:24085-24089.
82. Bishop G.M., Dringen R., Robinson S.R. Zinc stimulates the production of toxic reactive oxygen species (ROS) and inhibits glutathione reductase in astrocytes. Free Radic Biol Med 2007, 42:1222-1230.
83. Kim D., Joe C.O., Han P.L. Extracellular and intracellular glutathione protects astrocytes from Zn2+-induced cell death. Neuroreport 2003, 14:187-190.
84. Mize C.E., Langdon R.G. Hepatic glutathione reductase. I. Purification and general kinetic properties. J Biol Chem 1962, 237:1589-1595.
85. Mize C.E., Thompson T.E., Langdon R.G. Hepatic glutathione reductase. II. Physical properties and mechanism of action. J Biol Chem 1962, 237:1596-1600.
86. Ryu R., Shin Y., Choi J.W., Min W., Ryu H., Choi C.R., et al. Depletion of intracellular glutathione mediates zinc-induced cell death in rat primary astrocytes. Exp Brain Res 2002, 143:257-263.
87. Parat M.O., Richard M.J., Beani J.C., Favier A. Involvement of zinc in intracellular oxidant/antioxidant balance. Biol Trace Elem Res 1997, 60:187-204.
88. Meister A., Anderson M.E. Glutathione. Annu Rev Biochem 1983, 52:711-760.
89. Splittgerber A.G., Tappel A.L. Inhibition of glutathione peroxidase by cadmium and other metal ions. Arch Biochem Biophys 1979, 197:534-542.
90. Sensi S.L., Jeng J.M. Rethinking the excitotoxic ionic milieu: the emerging role of Zn(2+) in ischemic neuronal injury. Curr Mol Med 2004, 4:87-111.
91. Kim E.Y., Koh J.Y., Kim Y.H., Sohn S., Joe E., Gwag B.J. Zn2+ entry produces oxidative neuronal necrosis in cortical cell cultures. Eur J Neurosci 1999, 11:327-334.
92. Lemire J., Mailloux R., Appanna V.D. Zinc toxicity alters mitochondrial metabolism and leads to decrease ATP production in hepatocytes. J Appl Toxicol 2008, 28:175-182.
93. May J.M., Contoreggi C.S. The mechanism of the insulin-like effects of ionic zinc. J Biol Chem 1982, 257:4362-4368.
94. Walther U.I., Muckter H., Fichtl B., Forth W. Influence of glutathione on zinc-mediated cellular toxicity. Biol Trace Elem Res 1999, 67:97-107.
95. Khan A.T., Graham T.C., Ogden L., Salwa S.A., Thompson S.J., et al. A two-generational reproductive toxicity study of zinc in rats. J Environ Sci Health B 2007, 42:403-415.
96. Gerhard G.S., Benko F.A., Allen R.G., Tresini M., Kalbach A., Cristofalo V.J., et al. Mitochondrial DNA mutation analysis in human skin fibroblasts from fetal, young, and old donors. Mech Ageing Dev 2002, 123:155-166.
97. Bohr V.A. Repair of oxidative DNA damage in nuclear and mitochondrial DNA, and some changes with aging in mammalian cells. Free Radic Biol Med 2002, 32:804-812.
98. Stevnsner T., Thorslund T., de Souza-Pinto N.C., Bohr V.A. Mitochondrial repair of 8-oxoguanine and changes with aging. Exp Gerontol 2002, 37:1189-1196.
99. Nzengue Y., Steiman R., Garrel C., Lefebvre E., Guiraud P. Oxidative stress and DNA damage induced by cadmium in the human keratinocyte HaCaT cell line: role of glutathione in the resistance to cadmium. Toxicology 2008, 243:193-206.
100. Hayakawa M., Ogawa T., Sugiyama S., Tanaka M., Ozawa T. Massive conversion of guanosine to 8-hydroxy-guanosine in mouse liver mitochondrial DNA by administration of azidothymidine. Biochem Biophys Res Commun 1991, 176:87-93.
101. Cadet J., Berger M., Douki T., Ravanat J.L. Oxidative damage to DNA: formation, measurement, and biological significance. Rev Physiol Biochem Pharmacol 1997, 131:1-87.
102. Tremblay S., Douki T., Cadet J., Wagner J.R. 2'-Deoxycytidine glycols, a missing link in the free radical-mediated oxidation of DNA. J Biol Chem 1999, 274:20833-20838.
103. Cadet J., Douki T., Pouget J.P., Ravanat J.L., Sauvaigo S. Effects of UV and visible radiations on cellular DNA. Curr Probl Dermatol 2001, 29:62-73.
104. Collins A.R. Alcohol and DNA damage. J Lab Clin Med 2000, 136:258-259.
105. Valko M., Rhodes C.J., Moncol J., Izakovic M., Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006, 160:1-40.
106. Halliwell B., Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 1993, 57:715S-724S. [discussion 24S-25S].
107. Feng Z., Hu W., Amin S., Tang M.S. Mutational spectrum and genotoxicity of the major lipid peroxidation product, trans-4-hydroxy-2-nonenal, induced DNA adducts in nucleotide excision repair-proficient and -deficient human cells. Biochemistry 2003, 42:7848-7854.
108. Nair J., Barbin A., Velic I., Bartsch H. Etheno DNA-base adducts from endogenous reactive species. Mutat Res 1999, 424:59-69.
109. Bohr V.A., Stevnsner T., de Souza-Pinto N.C. Mitochondrial DNA repair of oxidative damage in mammalian cells. Gene 2002, 286:127-134.
110. Angeloff A., Dubey I., Pratviel G., Bernadou J., Meunier B. Characterization of a 5'-aldehyde terminus resulting from the oxidative attack at C5' of a 2-deoxyribose on DNA. Chem Res Toxicol 2001, 14:1413-1420.
111. Breen A.P., Murphy J.A. Reactions of oxyl radicals with DNA. Free Radic Biol Med 1995, 18:1033-1077.
112. Von Sonntag C. The chemical basis of radiation biology 1987, Taylor Francis, London.
113. Chatgilialoglu C., Ferreri C., Bazzanini R., Guerra M., Choi S.Y., Emanuel C.J., et al. Models of DNA C1' radicals. Structural, spectral, and chemical properties of the thyminylmethyl radical and the 2'deoxyuridin-1'-yl radical. J Am Chem Soc 2000, 122:9525-9533.
114. Koreta M.R., Roupioz Y., Defrancq E., Bourdat A.G., Garcia J., Coulombeau C., Lhomme J. The 7-nitroindole nucleoside as a photochemical precursor of 2'-deoxyribonolactone: access to DNA fragments containing this oxidative abasic lesion. Chemistry 2000, 6:4163-4169.
115. Roupioz Y., Lhomme J., Kotera M. Chemistry of the 2-deoxyribonolactone lesion in oligonucleotides: cleavage kinetics and products analysis. J Am Chem Soc 2002, 124:9129-9135.
116. DeMott M.S., Beyret E., Wong D., Bales B.C., Hwang J.T., Greenberg M.M., et al. Covalent trapping of human DNA polymerase beta by the oxidative DNA lesion 2-deoxyribonolactone. J Biol Chem 2002, 277:7637-7640.
117. Hashimoto M., Greenberg M.M., Kow Y.W., Hwang J.T., Cunningham R.P. The 2-deoxyribonolactone lesion produced in DNA by neocarzinostatin and other damaging agents forms cross-links with the base-excision repair enzyme endonuclease III. J Am Chem Soc 2001, 123:3161-3162.
118. Xu Y.J., DeMott M.S., Hwang J.T., Greenberg M.M., Demple B. Action of human apurinic endonuclease (Ape 1) on C1'-oxidized deoxyribose damage in DNA. DNA Repair (Amst) 2003, 3:175-185.
119. Blair I.A. Lipid hydroperoxide-mediated DNA damage. Exp Gerontol 2001, 36:1473-1481.
120. Marnett L.J. Oxyradicals and DNA damage. Carcinogenesis 2000, 21:361-370.
121. Marnett L.J. Oxy radicals, lipid peroxidation and DNA damage. Toxicology 2002, 181-182:219-222.
122. Marnett L.J., Basu A.K., O'Hara S.M. The role of cyclic nucleic acid adducts in the mutational specificity of malondialdehyde and beta-substituted acroleins in Salmonella. IARC Sci Publ 1986, 175-183.
123. Marnett L.J., Basu A.K., O'Hara S.M., Weller P.E., Rahman A.F.M.M., Oliver J.P. Reaction of malondialdehyde with guanine nucleosides: formation of adducts containing oxadiazabicyclononene residues in the base-pairing region. J Am Chem Soc 1986, 108:1348-1350.
124. Nair V., Turner G.A., Offman R.J. Novel adducts from the modification of nucleic acid bases by malondialdehyde. J Am Chem Soc 1984, 106:3370-3371.
125. Seto H., Okuda T., Takesue T., Ikemura T. Bull Soc Jpn 1983, 56:1799-1802.
126. Stone K., Ksebati M.B., Marnett L.J. Investigation of the adducts formed by reaction of malondialdehyde with adenosine. Chem Res Toxicol 1990, 3:33-38.
127. Stone K., Uzieblo A., Marnett L.J. Studies of the reaction of malondialdehyde with cytosine nucleosides. Chem Res Toxicol 1990, 3:467-472.
128. Basu A.K., Marnett L.J. Unequivocal demonstration that malondialdehyde is a mutagen. Carcinogenesis 1983, 4:331-333.
129. Falletti O., Cadet J., Favier A., Douki T. Trapping of 4-hydroxynonenal by glutathione efficiently prevents formation of DNA adducts in human cells. Free Radic Biol Med 2007, 42:1258-1269.
130. Seto H., Akiyam K., Okuda T., Hashimoto T., Takesue T., Ikemura T. Structure of a new modifiedbnucleoside formed by guanosine-malonaldehyde reaction. Chem Lett 1981, 707-708.
131. Niedernhofer L.J., Daniels J.S., Rouzer C.A., Greene R.E., Marnett L.J. Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells. J Biol Chem 2003, 278:31426-31433.
132. Schauenstein E. Autoxidation of polyunsaturated esters in water: chemical structure and biological activity of the products. J Lipid Res 1967, 8:417-428.
133. Esterbauer H., Puhl H., Dieber-Rotheneder M., Waeg G., Rabl H. Effect of antioxidants on oxidative modification of LDL. Ann Med 1991, 23:573-581.
134. Douki T., Odin F., Caillat S., Favier A., Cadet J. Predominance of the 1,N2-propano 2'-deoxyguanosine adduct among 4-hydroxy-2-nonenal-induced DNA lesions. Free Radic Biol Med 2004, 37:62-70.
135. Kowalczyk P., Ciesla J.M., Komisarski M., Kusmierek J.T., Tudek B. Long-chain adducts of trans-4-hydroxy-2-nonenal to DNA bases cause recombination, base substitutions and frameshift mutations in M13 phage. Mutat Res 2004, 550:33-48.
136. Lee S.H., Arora J.A., Oe T., Blair I.A. 4-Hydroperoxy-2-nonenal-induced formation of 1,N2-etheno-2'-deoxyguanosine adducts. Chem Res Toxicol 2005, 18:780-786.
137. Rindgen D., Nakajima M., Wehrli S., Xu K., Blair I.A. Covalent modifications to 2'-deoxyguanosine by 4-oxo-2-nonenal, a novel product of lipid peroxidation. Chem Res Toxicol 1999, 12:1195-1204.
138. Lee S.H., Blair I.A. Characterization of 4-oxo-2-nonenal as a novel product of lipid peroxidation. Chem Res Toxicol 2000, 13:698-702.
139. Lee S.H., Rindgen D., Bible R.H., Hajdu E., Blair I.A. Characterization of 2'-deoxyadenosine adducts derived from 4-oxo-2-nonenal, a novel product of lipid peroxidation. Chem Res Toxicol 2000, 13:565-574.
140. Rindgen D., Lee S.H., Nakajima M., Blair I.A. Formation of a substituted 1,N(6)-etheno-2'-deoxyadenosine adduct by lipid hydroperoxide-mediated generation of 4-oxo-2-nonenal. Chem Res Toxicol 2000, 13:846-852.
141. Pollack M., Oe T., Lee S.H., Silva Elipe M.V., Arison B.H., Blair I.A. Characterization of 2'-deoxycytidine adducts derived from 4-oxo-2-nonenal, a novel lipid peroxidation product. Chem Res Toxicol 2003, 16:893-900.
142. Davies M.J., Fu S., Dean R.T. Protein hydroperoxides can give rise to reactive free radicals. Biochem J 1995, 305(Pt 2):643-649.
143. Furukawa A., Hiraku Y., Oikawa S., Luxford C., Davies M.J., Kawanishi S. Guanine-specific DNA damage induced by gamma-irradiated histone. Biochem J 2005, 388:813-818.
144. Luxford C., Dean R.T., Davies M.J. Induction of DNA damage by oxidised amino acids and proteins. Biogerontology 2002, 3:95-102.
145. Luxford C., Morin B., Dean R.T., Davies M.J. Histone H1- and other protein- and amino acid-hydroperoxides can give rise to free radicals which oxidize DNA. Biochem J 1999, 344(Pt 1):125-134.
146. Termini J. Hydroperoxide-induced DNA damage and mutations. Mutat Res 2000, 450:107-124.
147. Gebicki S., Gebicki J.M. Crosslinking of DNA and proteins induced by protein hydroperoxides. Biochem J 1999, 338(Pt 3):629-636.
148. Pathak N., Khandelwal S. Influence of cadmium on murine thymocytes: potentiation of apoptosis and oxidative stress. Toxicol Lett 2006, 165:121-132.
149. Hatcher E.L., Chen Y., Kang Y.J. Cadmium resistance in A549 cells correlates with elevated glutathione content but not antioxidant enzymatic activities. Free Radic Biol Med 1995, 19:805-812.
150. Shukla G.S., Shukla A., Potts R.J., Osier M., Hart B.A., Chiu J.F. Cadmium-mediated oxidative stress in alveolar epithelial cells induces the expression of gamma-glutamylcysteine synthetase catalytic subunit and glutathione S-transferase alpha and pi isoforms: potential role of activator protein-1. Cell Biol Toxicol 2000, 16:347-362.
151. Bump E.A., Brown J.M. Role of glutathione in the radiation response of mammalian cells in vitro and in vivo. Pharmacol Ther 1990, 47:117-136.
152. Hanna P.M., Mason R.P. Direct evidence for inhibition of free radical formation from Cu(I) and hydrogen peroxide by glutathione and other potential ligands using the EPR spin-trapping technique. Arch Biochem Biophys 1992, 295:205-213.
153. Arrigo A.P. Gene expression and the thiol redox state. Free Radic Biol Med 1999, 27:936-944.
154. Biswas S., Chida A.S., Rahman I. Redox modifications of protein-thiols: emerging roles in cell signaling. Biochem Pharmacol 2006, 71:551-564.
155. Piette J., Piret B., Bonizzi G., Schoonbroodt S., Merville M.P., Legrand-Poels S., et al. Multiple redox regulation in NF-kappaB transcription factor activation. Biol Chem 1997, 378:1237-1245.
156. Lafleur M.V., Hoorweg J.J., Joenje H., Westmijze E.J., Retel J. The ambivalent role of glutathione in the protection of DNA against singlet oxygen. Free Radic Res 1994, 21:9-17.
157. Griffith O.W. Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic Biol Med 1999, 27:922-935.
158. Al-Mutairi D.A., Craik J.D., Batinic-Haberle I., Benov L.T. Induction of oxidative cell damage by photo-treatment with zinc meta N-methylpyridylporphyrin. Free Radic Res 2007, 41:89-96.
159. Dufresne J., Cyr D.G. Effects of short-term methylmercury exposure on metallothionein mRNA levels in the testis and epididymis of the rat. J Androl 1999, 20:769-778.
160. Masters B.A., Quaife C.J., Erickson J.C., Kelly E.J., Froelick G.J., Zambrowicz B.P., et al. Metallothionein III is expressed in neurons that sequester zinc in synaptic vesicles. J Neurosci 1994, 14:5844-5857.
161. Moffatt P., Seguin C. Expression of the gene encoding metallothionein-3 in organs of the reproductive system. DNA Cell Biol 1998, 17:501-510.
162. Palmiter R.D., Findley S.D., Whitmore T.E., Durnam D.M. MT-III, a brain-specific member of the metallothionein gene family. Proc Natl Acad Sci USA 1992, 89:6333-6337.
163. Ganguly S., Taioli E., Baranski B., Cohen B., Toniolo P., Garte S.J. Human metallothionein gene expression determined by quantitative reverse transcription-polymerase chain reaction as a biomarker of cadmium exposure. Cancer Epidemiol Biomarkers Prev 1996, 5:297-301.
164. Lu J., Jin T., Nordberg G., Nordberg M. Metallothionein gene expression in peripheral lymphocytes from cadmium-exposed workers. Cell Stress Chaperones 2001, 6:97-104.
165. Amiard J.C., Cosson R.P. Les métallothionéines. Biomarqueurs en écotoxicologie 1997, 53-66. Masson, Paris. L. Lagadic, T. Caquet, J.-C. Amiard, F. Ramade (Eds.).
166. Viarengo A., Burlando B., Cavaletto M., Marchi B., Ponzano E., Blasco J. Role of metallothionein against oxidative stress in the mussel Mytilus galloprovincialis. Am J Physiol 1999, 277:R1612-R1619.
167. Kagi J.H. Overview of metallothionein. Methods Enzymol 1991, 205:613-626.
168. Kang Y.J. Metallothionein redox cycle and function. Exp Biol Med (Maywood) 2006, 231:1459-1467.
169. Shaw C.F., Petering D.H., Laib J.E., Savas M.M., Melnick K. In vitro preparation and characterization of aurothioneins. Methods Enzymol 1991, 205:469-475.
170. Shaw C.F., Savas M.M., Petering D.H. Ligand substitution and sulfhydryl reactivity of metallothionein. Methods Enzymol 1991, 205:401-414.
171. Feng W., Benz F.W., Cai J., Pierce W.M., Kang Y.J. Metallothionein disulfides are present in metallothionein-overexpressing transgenic mouse heart and increase under conditions of oxidative stress. J Biol Chem 2006, 281:681-687.
172. Maret W. Metallothionein/disulfide interactions, oxidative stress, and the mobilization of cellular zinc. Neurochem Int 1995, 27:111-117.
173. Maret W. The function of zinc metallothionein: a link between cellular zinc and redox state. J Nutr 2000, 130:1455S-1458S.
174. Duncan K.E., Ngu T.T., Chan J., Salgado M.T., Merrifield M.E., Stillman M.J. Peptide folding, metal-binding mechanisms, and binding site structures in metallothioneins. Exp Biol Med (Maywood) 2006, 231:1488-1499.
175. Ejnik J., Robinson J., Zhu J., Forsterling H., Shaw C.F., Petering D.H. Folding pathway of apo-metallothionein induced by Zn2+, Cd2+ and Co2+. J Inorg Biochem 2002, 88:144-152.
176. Nielson K.B., Atkin C.L., Winge D.R. Distinct metal-binding configurations in metallothionein. J Biol Chem 1985, 260:5342-5350.
177. Nielson K.B., Winge D.R. Order of metal binding in metallothionein. J Biol Chem 1983, 258:13063-13069.
178. Nielson K.B., Winge D.R. Independence of the domains of metallothionein in metal binding. J Biol Chem 1985, 260:8698-8701.
179. Nielson K.B., Winge D.R. Preferential binding of copper to the beta domain of metallothionein. J Biol Chem 1984, 259:4941-4946.
180. Hamer D.H. Metallothionein. Annu Rev Biochem 1986, 55:913-951.
181. Kagi J.H., Schaffer A. Biochemistry of metallothionein. Biochemistry 1988, 27:8509-8515.
182. Beattie J.H., Owen H.L., Wallace S.M., Arthur J.R., Kwun I.S., Hawksworth G.M., et al. Metallothionein overexpression and resistance to toxic stress. Toxicol Lett 2005, 157:69-78.
183. Nzengue Y., Lefebvre E., Cadet J., Favier A., Rachidi W., Steiman R., et al. Metallothionein expression in HaCaT and C6 cell lines exposed to cadmium. J Trace Elem Med Biol 2009, 23:314-323.
184. Cherian M.G., Huang P.C., Klaassen C.D., Liu Y.P., Longfellow D.G., Waalkes M.P. National Cancer Institute workshop on the possible roles of metallothionein in carcinogenesis. Cancer Res 1993, 53:922-925.
185. Moffatt P., Denizeau F. Metallothionein in physiological and physiopathological processes. Drug Metab Rev 1997, 29:261-307.
186. Ogra Y., Aoyama M., Suzuki K.T. Protective role of metallothionein against copper depletion. Arch Biochem Biophys 2006, 451:112-118.
187. Palmiter R.D. The elusive function of metallothioneins. Proc Natl Acad Sci USA 1998, 95:8428-8430.
188. Suzuki T., Yamanaka H., Nakajima K., Kanatani K., Suzuki K., Kimura M., et al. Induction of metallothionein by CdCl2 administration in rat prostate. Prostate 1993, 22:163-170.
189. McAleer M.F., Tuan R.S. Metallothionein protects against severe oxidative stress-induced apoptosis of human trophoblastic cells. In Vitro Mol Toxicol 2001, 14:219-231.
190. McAleer M.F., Tuan R.S. Metallothionein overexpression in human trophoblastic cells protects against cadmium-induced apoptosis. In Vitro Mol Toxicol 2001, 14:25-42.
191. Abel J., de Ruiter N. Inhibition of hydroxyl-radical-generated DNA degradation by metallothionein. Toxicol Lett 1989, 47:191-196.
192. Rossman T.G., Roy N.K., Lin W.C. Is cadmium genotoxic?. IARC Sci Publ 1992, 367-375.
193. Andrews G.K. Regulation of metallothionein gene expression. Prog Food Nutr Sci 1990, 14:193-258.
194. Andrews G.K. Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem Pharmacol 2000, 59:95-104.
195. Ghoshal K., Majumder S., Li Z., Dong X., Jacob S.T. Suppression of metallothionein gene expression in a rat hepatoma because of promoter-specific DNA methylation. J Biol Chem 2000, 275:539-547.
196. Moilanen L.H., Fukushige T., Freedman J.H. Regulation of metallothionein gene transcription. Identification of upstream regulatory elements and transcription factors responsible for cell-specific expression of the metallothionein genes from Caenorhabditis elegans. J Biol Chem 1999, 274:29655-29665.
197. Otsuka F. Mocular mechanism of the metallothionein gene expression mediated by metal-responsive transcription factor 1. J Health Sci 2001, 47:513-519.
198. Samson S.L., Gedamu L. Molecular analyses of metallothionein gene regulation. Prog Nucleic Acid Res Mol Biol 1998, 59:257-288.
199. Friedline J.A., Garrett S.H., Somji S., Todd J.H., Sens D.A. Differential expression of the MT-1E gene in estrogen-receptor-positive and -negative human breast cancer cell lines. Am J Pathol 1998, 152:23-27.
200. Jin R., Bay B.H., Chow V.T., Tan P.H., Lin V.C. Metallothionein 1E mRNA is highly expressed in oestrogen receptor-negative human invasive ductal breast cancer. Br J Cancer 2000, 83:319-323.
201. Sadhu C., Gedamu L. Metal-specific posttranscriptional control of human metallothionein genes. Mol Cell Biol 1989, 9:5738-5741.
202. Vasconcelos M.H., Tam S.C., Beattie J.H., Hesketh J.E. Evidence for differences in the post-transcriptional regulation of rat metallothionein isoforms. Biochem J 1996, 315(Pt 2):665-671.
203. Westin G., Schaffner W. A zinc-responsive factor interacts with a metal-regulated enhancer element (MRE) of the mouse metallothionein-I gene. EMBO J 1988, 7:3763-3770.
204. Lichtlen P., Schaffner W. The " metal transcription factor" MTF-1: biological facts and medical implications. Swiss Med Wkly 2001, 131:647-652.
205. Lichtlen P., Wang Y., Belser T., Georgiev O., Certa U., Sack R., et al. Target gene search for the metal-responsive transcription factor MTF-1. Nucleic Acids Res 2001, 29:1514-1523.
206. Jiang H., Daniels P.J., Andrews G.K. Putative zinc-sensing zinc fingers of metal-response element-binding transcription factor-1 stabilize a metal-dependent chromatin complex on the endogenous metallothionein-I promoter. J Biol Chem 2003, 278:30394-30402.
207. Palmiter R.D. Regulation of metallothionein genes by heavy metals appears to be mediated by a zinc-sensitive inhibitor that interacts with a constitutively active transcription factor, MTF-1. Proc Natl Acad Sci USA 1994, 91:1219-1223.
208. Saydam N., Steiner F., Georgiev O., Schaffner W. Heat and heavy metal stress synergize to mediate transcriptional hyperactivation by metal-responsive transcription factor MTF-1. J Biol Chem 2003, 278:31879-31883.
209. Radtke F., Georgiev O., Muller H.P., Brugnera E., Schaffner W. Functional domains of the heavy metal-responsive transcription regulator MTF-1. Nucleic Acids Res 1995, 23:2277-2286.
210. Radtke F., Heuchel R., Georgiev O., Hergersberg M., Gariglio M., Dembic Z., et al. Cloned transcription factor MTF-1 activates the mouse metallothionein I promoter. EMBO J 1993, 12:1355-1362.
211. Heuchel R., Radtke F., Georgiev O., Stark G., Aguet M., Schaffner W. The transcription factor MTF-1 is essential for basal and heavy metal-induced metallothionein gene expression. EMBO J 1994, 13:2870-2875.
212. Laity J.H., Chung J., Dyson H.J., Wright P.E. Alternative splicing of Wilms' tumor suppressor protein modulates DNA binding activity through isoform-specific DNA-induced conformational changes. Biochemistry 2000, 39:5341-5348.
213. Laity J.H., Dyson H.J., Wright P.E. DNA-induced alpha-helix capping in conserved linker sequences is a determinant of binding affinity in Cys(2)-His(2) zinc fingers. J Mol Biol 2000, 295:719-727.
214. Li X., Chen H., Epstein P.N. Metallothionein and catalase sensitize to diabetes in nonobese diabetic mice: reactive oxygen species may have a protective role in pancreatic beta-cells. Diabetes 2006, 55:1592-1604.
215. Bittel D.C., Smirnova I.V., Andrews G.K. Functional heterogeneity in the zinc fingers of metalloregulatory protein metal response element-binding transcription factor-1. J Biol Chem 2000, 275:37194-37201.
216. Daniels P.J., Bittel D., Smirnova I.V., Winge D.R., Andrews G.K. Mammalian metal response element-binding transcription factor-1 functions as a zinc sensor in yeast, but not as a sensor of cadmium or oxidative stress. Nucleic Acids Res 2002, 30:3130-3140.
217. Chen X., Chu M., Giedroc D.P. MRE-Binding transcription factor-1: weak zinc-binding finger domains 5 and 6 modulate the structure, affinity, and specificity of the metal-response element complex. Biochemistry 1999, 38:12915-12925.
218. Koizumi S., Suzuki K., Ogra Y., Gong P., Otuska F. Roles of zinc fingers and other regions of the transcription factor human MTF-1 in zinc-regulated DNA binding. J Cell Physiol 2000, 185:464-472.
219. Otsuka F., Okugaito I., Ohsawa M., Iwamatsu A., Suzuki K., Koizumi S. Novel responses of ZRF, a variant of human MTF-1, to in vivo treatment with heavy metals. Biochim Biophys Acta 2000, 1492:330-340.
220. Culotta V.C., Hamer D.H. Fine mapping of a mouse metallothionein gene metal response element. Mol Cell Biol 1989, 9:1376-1380.
221. Koizumi S., Suzuki K., Ogra Y., Yamada H., Otsuka F. Transcriptional activity and regulatory protein binding of metal-responsive elements of the human metallothionein-IIA gene. Eur J Biochem 1999, 259:635-642.
222. Stuart G.W., Searle P.F., Palmiter R.D. Identification of multiple metal regulatory elements in mouse metallothionein-I promoter by assaying synthetic sequences. Nature 1985, 317:828-831.
223. Hawse J.R., Padgaonkar V.A., Leverenz V.R., Pelliccia S.E., Kantorow M., Giblin F.J. The role of metallothionein IIa in defending lens epithelial cells against cadmium and TBHP induced oxidative stress. Mol Vis 2006, 12:342-349.
224. Saydam N., Adams T.K., Steiner F., Schaffner W., Freedman J.H. Regulation of metallothionein transcription by the metal-responsive transcription factor MTF-1: identification of signal transduction cascades that control metal-inducible transcription. J Biol Chem 2002, 277:20438-20445.
225. Wimmer U., Wang Y., Georgiev O., Schaffner W. Two major branches of anti-cadmium defense in the mouse: MTF-1/metallothioneins and glutathione. Nucleic Acids Res 2005, 33:5715-5727.
226. Sakamuro D., Sabbatini P., White E., Prendergast G.C. The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene 1997, 15:887-898.
227. Selivanova G., Iotsova V., Okan I., Fritsche M., Strom M., Groner B., et al. Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain. Nat Med 1997, 3:632-638.
228. Paramio J.M., Segrelles C., Lain S., Gomez-Casero E., Lane D.P., Lane E.B., et al. p53 is phosphorylated at the carboxyl terminus and promotes the differentiation of human HaCaT keratinocytes. Mol Carcinog 2000, 29:251-262.
229. Fisher D.E. Apoptosis in cancer therapy: crossing the threshold. Cell 1994, 78:539-542.
230. Oren M. Decision making by p53: life, death and cancer. Cell Death Differ 2003, 10:431-442.
231. Cao F., Zhou T., Simpson D., Zhou Y., Boyer J., Chen B., et al. p53-Dependent but ATM-independent inhibition of DNA synthesis and G2 arrest in cadmium-treated human fibroblasts. Toxicol Appl Pharmacol 2007, 218:174-185.
232. Ko L.J., Prives C. p53: puzzle and paradigm. Genes Dev 1996, 10:1054-1072.
233. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 1997, 88:323-331.
234. Meplan C., Mann K., Hainaut P. Cadmium induces conformational modifications of wild-type p53 and suppresses p53 response to DNA damage in cultured cells. J Biol Chem 1999, 274:31663-31670.
235. Witkiewicz-Kucharczyk A., Bal W. Damage of zinc fingers in DNA repair proteins, a novel molecular mechanism in carcinogenesis. Toxicol Lett 2006, 162:29-42.
236. Joseph P., Muchnok T.K., Klishis M.L., Roberts J.R., Antonini J.M., Whong W.Z., et al. Cadmium-induced cell transformation and tumorigenesis are associated with transcriptional activation of c-fos, c-jun, and c-myc proto-oncogenes: role of cellular calcium and reactive oxygen species. Toxicol Sci 2001, 61:295-303.
237. Cherian M.G., Apostolova M.D. Nuclear localization of metallothionein during cell proliferation and differentiation. Cell Mol Biol (Noisy-le-grand) 2000, 46:347-356.
238. Klaassen C.H., Jeunink M.A., Prinsen C.F., Ruers T.J., Tan A.C., Strobbe L.J., et al. Quantification of human DNA in feces as a diagnostic test for the presence of colorectal cancer. Clin Chem 2003, 49:1185-1187.
239. Lazo J.S., Kuo S.M., Woo E.S., Pitt B.R. The protein thiol metallothionein as an antioxidant and protectant against antineoplastic drugs. Chem Biol Interact 1998, 111-112:255-262.
240. Meplan C., Richard M.J., Hainaut P. Metalloregulation of the tumor suppressor protein p53: zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intact cells. Oncogene 2000, 19:5227-5236.
241. Meplan C., Richard M.J., Hainaut P. Redox signalling and transition metals in the control of the p53 pathway. Biochem Pharmacol 2000, 59:25-33.
242. Rainwater R., Parks D., Anderson M.E., Tegtmeyer P., Mann K. Role of cysteine residues in regulation of p53 function. Mol Cell Biol 1995, 15:3892-3903.
243. Hainaut P., Milner J. A structural role for metal ions in the " wild-type" conformation of the tumor suppressor protein p53. Cancer Res 1993, 53:1739-1742.
244. Ostrakhovitch E.A., Olsson P.E., Jiang S., Cherian M.G. Interaction of metallothionein with tumor suppressor p53 protein. FEBS Lett 2006, 580:1235-1238.
245. Motti M., De Marco C., Califano D., Fusco A., Viglietto G. Akt-dependent T198 phosphorylation of cyclin-dependent kinase inhibitor p27kip1 in breast cancer. Cell Cycle 2004, 3:1074-1080.
246. Ostrakhovitch E.A., Olsson P.E., von Hofsten J., Cherian M.G. p53 mediated regulation of metallothionein transcription in breast cancer cells. J Cell Biochem 2007, 102:1571-1583.
247. Shin I., Rotty J., Wu F.Y., Arteaga C.L. Phosphorylation of p27kip1 at Thr-157 interferes with its association with importin alpha during G1 and prevents nuclear re-entry. J Biol Chem 2005, 280:6055-6063.
248. Singh B., Reddy P.G., Goberdhan A., Walsh C., Dao S., Ngai I., et al. p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas. Genes Dev 2002, 16:984-993.
249. Nzengue Y., Steiman R., Guiraud P. Characterization of the cell death induced by cadmium in HaCaT and C6 cell lines. Free Radic Res 2008, 42:142-153.